PIERINI, ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 2.032
EU - Europa 1.514
AS - Asia 1.465
SA - Sud America 313
AF - Africa 32
OC - Oceania 4
Totale 5.360
Nazione #
US - Stati Uniti d'America 1.989
SG - Singapore 695
IT - Italia 462
CN - Cina 301
IE - Irlanda 293
BR - Brasile 273
HK - Hong Kong 222
RU - Federazione Russa 164
DE - Germania 122
FI - Finlandia 109
KR - Corea 74
VN - Vietnam 71
SE - Svezia 55
GB - Regno Unito 49
UA - Ucraina 47
AT - Austria 46
FR - Francia 46
TR - Turchia 24
PL - Polonia 23
IN - India 22
CA - Canada 19
CZ - Repubblica Ceca 19
MX - Messico 19
NL - Olanda 18
AR - Argentina 16
BE - Belgio 13
CH - Svizzera 13
EC - Ecuador 11
ZA - Sudafrica 10
BD - Bangladesh 9
JP - Giappone 9
RO - Romania 8
ID - Indonesia 5
IL - Israele 5
LT - Lituania 5
IQ - Iraq 4
KE - Kenya 4
PT - Portogallo 4
UZ - Uzbekistan 4
VE - Venezuela 4
AU - Australia 3
BA - Bosnia-Erzegovina 3
BG - Bulgaria 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
MA - Marocco 3
PE - Perù 3
AO - Angola 2
BO - Bolivia 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
ES - Italia 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
PH - Filippine 2
PK - Pakistan 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CM - Camerun 1
CO - Colombia 1
DJ - Gibuti 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
KG - Kirghizistan 1
KI - Kiribati 1
LV - Lettonia 1
ML - Mali 1
MR - Mauritania 1
MY - Malesia 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TL - Timor Orientale 1
TW - Taiwan 1
ZM - Zambia 1
Totale 5.360
Città #
Singapore 465
Dublin 293
Chandler 253
San Mateo 240
Hong Kong 220
Perugia 178
Boardman 165
Ashburn 118
Santa Clara 104
Altamura 75
Seoul 74
Beijing 67
Moscow 66
Munich 64
Andover 60
Medford 59
Princeton 58
Lawrence 55
Wilmington 53
Turku 51
Los Angeles 49
Ann Arbor 38
New York 36
Vienna 36
Piscataway 29
Ho Chi Minh City 27
Helsinki 26
São Paulo 22
Des Moines 21
Redmond 20
San Paolo di Civitate 20
Bologna 19
Nuremberg 18
Rome 18
Frankfurt am Main 17
Jacksonville 16
Hanoi 15
Hefei 15
Norwalk 15
Brooklyn 14
London 14
Milan 14
Warsaw 14
Dearborn 13
Falls Church 13
Brno 12
Brussels 12
Florence 12
Dallas 11
Denver 11
Houston 11
Rio de Janeiro 11
Saint Petersburg 11
Atlanta 10
Chicago 10
Phoenix 10
Boston 9
Council Bluffs 8
Groningen 8
Guangzhou 8
Johannesburg 8
Lappeenranta 8
Redwood City 8
Stockholm 8
The Dalles 8
Tokyo 8
West Jordan 8
Bucharest 7
Falkenstein 7
Izmir 7
Terni 7
Amsterdam 6
Foligno 6
Padova 6
Poplar 6
San Francisco 6
Ancona 5
Kocaeli 5
Manchester 5
Marsciano 5
Montreal 5
Orem 5
Quito 5
Seattle 5
Brasília 4
Changsha 4
Francavilla al Mare 4
Kiryat Ono 4
Lucca 4
Mexico City 4
Nairobi 4
Pouso Alegre 4
Secaucus 4
Shanghai 4
Tianjin 4
Toronto 4
Zhengzhou 4
Ankara 3
Arezzo 3
Aurora 3
Totale 3.626
Nome #
TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation 109
NOTCH1 inhibition prevents GvHD and maintains GvL effect in murine models 109
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 107
Clinical-Grade Expanded Regulatory T Cells Prevent Graft-versus-Host Disease While Allowing a Powerful T Cell Dependent Graft-versus-Leukemia Effect in Murine Models 104
"Designed" grafts for HLA-haploidentical stem cell transplantation. 99
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 96
T regulatory cell separation for clinical application. 95
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 93
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. 93
Activation of Regulatory T Cells with IL-2 and TNF-alpha to Promote Homing to the Gut and to Improve Acute GvHD Prevention 91
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 91
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 89
CMV management with specific immunoglobulins: A multicentric retrospective analysis on 92 allotransplanted patients 88
Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiation 87
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 87
Genetically-determined hyperfunction of the S100B/RAGE axis is a risk factor for aspergillosis in stem cell transplant recipients 85
The effect of TNF-α on regulatory T cell function in graft-versus-host disease 85
CD4+FOXP3+ Regulatory T Cell Therapies in HLA Haploidentical Hematopoietic Transplantation 85
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 83
T cell depletion and no post transplant immune suppression allow separation of graft versus leukemia from graft versus host disease 81
Acute myeloid leukemia development soon after anti-CD19 chimeric antigen receptor T-cell infusion in a patient with refractory diffuse large B-cell lymphoma and pre-existing clonal hematopoiesis 80
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 80
HLA-MATCHED TREG/TCON ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION ENSURES REMARKABLE CHRONIC GVHD/LEUKEMIA FREE SURVIVAL IN HIGH-RISK LEUKEMIA PATIENTS 80
TLR3 essentially promotes protective class I-restricted memory CD8+ T-cell responses to Aspergillus fumigatus in hematopoietic transplanted patients. 78
Clinical-Grade Expanded Regulatory T Cells Are Enriched with Highly Suppressive Cells Producing IL-10, Granzyme B, and IL-35 77
Acute GvHD after HLA- Haploidentical Hematopoietic Cell Transplantation with Regulatory and Conventional T Cell Immunotherapy Does Not Adversely Affect Transplantation Outcomes 75
T cells expressing chimeric antigen receptor promote immune tolerance 74
New mechanism of lymphoma-induced bone marrow aplasia 74
ADOPTIVE IMMUNOTHERAPY WITH REGULATORY AND CONVENTIONAL T CELLS AFFORDS HIGH RATE OF CHRONIC GVHD/RELAPSE-FREE SURVIVAL IN ACUTE MYELOID LEUKEMIA AFTER MYELOABLATIVE HAPLOIDENTICAL TRANSPLANTATION 73
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 72
Case Report: Subtotal Lymphoid and Total Marrow Irradiation as Bridge Therapy to CD19-Directed CAR T Cells in a Chemorefractory DLBCL With Leukemic Involvement 70
NK cell reconstitution is improved during allogeneic hematopoietic stem cell transplantation by infusion of NK cell-committed progenitor cells (HEM5P. 233) 70
Foxp3+regulatory T cells maintain the bone marrow microenvironment for B cell lymphopoiesis 69
CD41 invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD41CD251FoxP31 regulatory T cells 69
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 67
FISH analysis reveals frequent co-occurrence of 4q24/TET2 and 5q and/or 7q deletions. 66
REGULATORY T CELL ADOPTIVE IMMUNOTHERAPY PROMOTES B CELL IMMUNITY AFTER HAPLOIDENTICAL TRANSPLANTATION 64
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 63
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease 61
HAPLOIDENTICAL TRANSPLANTATION WITH TREG-TCON ADOPTIVE IMMUNOTHERAPY FOR THE CURE OF ACUTE MYELOID LEUKEMIA WITH HIGH-RISK CYTOGENETICS 60
Mutational analisys of JAK2 VAL617PHE in a new series of chronic myelomonocytic leukemia and related atypical myeloproliferative disorders 60
Engraftment of Embryonic Stem Cells and Differentiated Progeny by Host Conditioning with Total Lymphoid Irradiation and Regulatory T Cells 60
Impact of Donor T Cells on NK Cell Development after Allogeneic Hematopoietic Cell Transplantation 60
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 59
The Leukemic Isocitrate Dehydrogenase (IDH) 1/2 Mutations Impair Myeloid and Erythroid Cell Differentiation of Primary Human Hematopoietic Stem and Progenitor Cells (HSPCs) 58
HLA-Matched Treg/Tcon Allogeneic Hematopoietic Cell Transplantation Is Safe and Ensures Remarkable Chronic GvHD/Leukemia Free Survival in High-Risk Leukemia Patients 56
Regulatory T Cell Adoptive Immunotherapy Promotes B Cell Immunity after Haploidentical Transplantation 56
CD4+FoxP3+ Regulatory T Cells Promote B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 56
Regulation of murine NK cell exhaustion through the activation of the DNA damage repair pathway 56
The Evolution of T Cell Depleted Haploidentical Transplantation 56
NPM1 monoallelic deletion in a subgroup of MDS/AML with del(5q) or monosomy 5 and complex karyotype 55
Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation 55
Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease 55
Chronic stimulation results in NK cell function impairment mediated by NKG2D 55
DR3 signaling modulates the function of Foxp3+regulatory T cells and the severity of acute graft-versus-host disease 55
Control of alloreactivity using transient expression of a monoclonal antibody directed chimeric antigen receptor in conventional and regulatory T cells 54
CD4+FoxP3+Regulatory T Cells Regulate B Cell Differentiation and Induce Tolerance to Bone Marrow Grafts 53
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 53
Feasibility of a Novel Sparse Orthogonal Collimator–Based Preclinical Total Marrow Irradiation for Enhanced Dosimetric Conformality 51
Host CD4+CD25+FoxP3+Regulatory T Cells Facilitate Donor Engraftment Without Impacting Graft Versus Host Disease Onset After Major-Mismatched Hematopoietic Stem Cell Transplantation 51
NPM1 haploinsufficiency in MDS/AML with del(5q)/monosomy 5 47
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Facilitate Conventional T Cell and Treg Control of GvHD and Tissue Tolerance in Murine Models 47
Venetoclax and Bortezomib in Relapsed/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia 47
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 46
TNF-α priming enhances CD4+FoxP3+regulatory T-cell suppressive function in murine GVHD prevention and treatment 46
Venetoclax plus azacitidine as genetic-driven bridge-to-transplant therapy for IDH2-mutated acute myeloid leukaemia (AML) refractory to intensive chemotherapy: proof-of-concept case reports 45
The Use of Monoclonal Antibody Directed Chimeric Antigen Receptors to Guide T Cell and Treg Homing for GvHD Control and Tissue Tolerance in Murine Models 45
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 45
HLA-haploidentical hematopoietic stem cells transplantation with regulatory and conventional T-cell adoptive immunotherapy in pediatric patients with very high-risk acute leukemia 45
TREG/TCON immunotherapy promotes HSC-derived B lymphopoiesis and boosts B cell immunity after haploidentical transplantation 44
TNF-Alpha Priming Enhances CD4(+) FoxP3(+) Regulatory T Cell Suppressive Function in GvHD Prevention and Treatment 43
Freeze and thaw of CD4+CD25+Foxp3+ regulatory T cells results in loss of CD62L expression and a reduced capacity to protect against graft-versus-host disease 43
Regulatory T Cell Immunotherapy in Immune-Mediated Diseases 43
Rifaximin use favoured micafungin-resistant Candida spp. infections in recipients of allogeneic hematopoietic cell transplantation 43
NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment 42
TIM-1 Blockade of the Donor Graft Provides Protection Against Lethal Gvhd 41
Total marrow irradiation reduces organ damage and enhances tissue repair with the potential to increase the targeted dose of bone marrow in both young and old mice 40
TNF-Alpha Priming Enhances CD4+FoxP3+ Regulatory T Cell Suppressive Function in GVHD Prevention and Treatment 40
TIM-1 blockade of the donor graft provides protection against lethal GVHD 40
Third Party Invariant Natural Killer T Cells Protect from Lethal Graft-Versus-Host Disease through Donor CD4+CD25+FoxP3+ Regulatory T Cells 38
Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion 37
Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation 35
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 34
null 34
Mast cells suppress murine GVHD in a mechanism independent of CD4+ CD25+ regulatory T cells 33
Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation 31
First Multimodal, Three-Dimensional, Image-Guided Total Marrow Irradiation Model for Preclinical Bone Marrow Transplantation Studies 30
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 28
null 27
Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality 14
Role of donor regulatory T cell adoptive immunotherapy in B cell immunity after hematopoietic cell transplantation 14
Totale 5.580
Categoria #
all - tutte 29.403
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202159 0 0 0 0 0 6 7 2 15 8 17 4
2021/2022654 9 199 1 15 29 7 10 175 11 25 101 72
2022/2023947 63 212 12 53 62 91 5 39 335 11 48 16
2023/2024584 15 59 14 14 2 14 118 8 41 26 127 146
2024/20251.339 41 126 49 59 176 86 72 101 237 77 196 119
2025/20261.478 220 215 157 404 403 79 0 0 0 0 0 0
Totale 5.580